Enalapril ODT - Ethicare GmbH

Drug Profile

Enalapril ODT - Ethicare GmbH

Alternative Names: Enalapril maleate ODT - Ethicare GmBH; Enalapril ODMT; Enalapril orodispersible minitablet

Latest Information Update: 16 Aug 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Ethicare GmbH
  • Class Antihypertensives; Dipeptides; Esters; Heart failure therapies; Small molecules
  • Mechanism of Action ACE inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase III Heart failure

Most Recent Events

  • 16 Aug 2017 Chemical structure information added
  • 02 Aug 2017 No development reported - Phase-I for Heart failure (In volunteers) in Belgium (PO)
  • 15 Mar 2016 Biomarkers information updated
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top